Enabling patients with autoimmune diseases to reimagine life.
Zenas BioPharma is a clinical-stage global biopharmaceutical company focused on developing and commercializing transformative immunology-based therapies for autoimmune diseases with significant unmet patient needs. The company's proven leadership team advances a pipeline targeting conditions where current treatments remain inadequate. Zenas operates with a global development model, combining scientific rigor with commercial strategy.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountSep 2024
May 2024
Nov 2022
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Health insurance company using technology to make health care simple, affordable, and accessible.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
